Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells

Clinical Cancer Research

Volumn 7, Issue 3, 2001, Pages 661-668

  Honjo, Y ^a   Nangia Makker, P ^a   Inohara, H ^a   Raz, A ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTIGENS, DIFFERENTIATION; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; DOWN-REGULATION; GALECTIN 3; HUMANS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; PLASMIDS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034904150     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Galectins: A family of animal β-galactoside-binding lectins
2. Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts
3. Human IgE-binding protein: A soluble lectin exhibiting a highly conserved interspecies and differential recognition of IgE glycoforms
4. Molecular cloning and chromosomal mapping of a human galactoside-binding protein
5. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages
6. Expression of an endogenous galactoside-binding lectin correlates with neoplastic progression in the colon
7. Expression of a 31 kDa lactose-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas
8. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications
9. Galectin-3 is a presurgical marker of human thyroid carcinoma
10. Expression of galectin-3 in fine needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
11. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system
12. Differential expression of the 67 kD laminin receptor and 31 kD human laminin-binding protein in human ovarian carcinomas
13. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast cancer cells
14. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line
15. Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin-3
16. Endogenous galactoside-binding lectins: A new class of functional tumor cell surface molecules related to metastasis
17. Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid medium
18. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro
19. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
20. Structure and function of a large family of animal lectins
21. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
22. Galectins: An evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy
23. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
24. Antisense inhibition of oncogene expression
25. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA
26. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis
27. Lymphotrophic virus I infection of human T lymphocytes induces expression of the β-galactoside-binding lectin, galectin-3
28. Decreased expression of Mac-2 (carbohydrate-binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma
29. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma
30. Alteration of the cytoplasmic/nuclear expression pattern of galectin correlates with prostate cancer
31. Carbohydrate-binding protein 35: Levels of transcription and mRNA accumulation in quiescent and proliferating cells
32. Galectin- 3 is a nuclear matrix protein which binds RNA
33. Identification of galectin-3 as a factor in pre-mRNA splicing
34. Differential expression of galectin-3 and galectin-1 in colorectal cancer progression
35. Expression of galectins in head and neck squamous cell carcinoma
36. Galectin-3 and L 1 retrotransposons in human breast carcinomas
37. 2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells